Emi Noguchi

Breast cancer

Cancer immunotherapy beyond immune checkpoint inhibitors

Reading the glyco-code: New approaches to studying protein–carbohydrate interactions

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Deep learning in histopathology: the path to the clinic

Multi-Field-of-View Deep Learning Model Predicts Nonsmall Cell Lung Cancer Programmed Death-Ligand 1 Status from Whole-Slide Hematoxylin and Eosin Images

Immune Landscape of Breast Cancers

Sialic Acid Ligands of CD28 Suppress Costimulation of T Cells

Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer

Phase 1/2, multicenter, non-randomized, open-label, multiple-dose first-in-human study of U3-1402 (anti-HER3 antibody drug conjugate) in subjects with HER3-positive metastatic breast cancer.